Ciro Celsa

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 27

Top Topics

Hepatitis C Virus

Liver Metastases

Ejection Fraction

Radiofrequency Ablation

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Hepatology (Baltimore, Md.)

Liver international : official journal of the International Association for the Study of the Liver

This page only lists publications with an associated author ORCID identifier.

Publications

David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and preliminary efficacy of pembrolizumab following trans-arterial chemoembolization for hepatocellular carcinoma: the PETAL phase Ib study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea, Bernhard Scheiner, Antonio D'Alessio, Giulia F Manfredi, Bernardo Stefanini, Naoshi Nishida, Peter R Galle, Kornelius Schulze, Henning Wege, Roberta Ciccia, Wei-Fan Hsu, Caterina Vivaldi, Brooke Wietharn, Ryan Po-Ting Lin, Angelo Pirozzi, Tiziana Pressiani, Andrea Dalbeni, Leonardo A Natola, Alessandra Auriemma, Cristina Rigamonti, Michela Burlone, Alessandro Parisi, Yi-Hsiang Huang, Pei-Chang Lee, Celina Ang, Thomas U Marron, Matthias Pinter, Jaekyung Cheon, Samuel Phen, Amit G Singal, Anuhya Gampa, Anjana Pillai, Natascha Roehlen, Robert Thimme, Arndt Vogel, Noha Soror, Susanna Ulahannan, Rohini Sharma, David Sacerdoti, Mario Pirisi, Lorenza Rimassa, Chun-Yen Lin, Anwaar Saeed, Gianluca Masi, Martin Schönlein, Johann von Felden, Masatoshi Kudo, Alessio Cortellini, Hong Jae Chon, Calogero Cammà, David James Pinato
Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology (Baltimore, Md.) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
David James Pinato, Antonio D'Alessio, Claudia Angela Maria Fulgenzi, Alexandra Emilia Schlaak, Ciro Celsa, Saskia Killmer, Jesus Miguens Blanco, Caroline Ward, Charalampos-Vlasios Stikas, Openshaw M R, Nicole Acuti, Georgios Nteliopoulos, Cristina Balcells, Hector C Keun, Robert D Goldin, Paul J Ross, Alessio Cortellini, Robert Thomas, Anna Mary Young, Nathan P Danckert, Paul Tait, Julian R Marchesi, Bertram Bengsch, Rohini Sharma
Safety and Preliminary Efficacy of Pembrolizumab Following Transarterial Chemoembolization for Hepatocellular Carcinoma: The PETAL Phase Ib Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (11) (2024)
Ciro Celsa, Giacomo Emanuele Maria Rizzo, Gabriele Di Maria, Marco Enea, Marco Vaccaro, Gabriele Rancatore, Pietro Graceffa, Giuseppe Falco, Salvatore Petta, Giuseppe Cabibbo, Vincenza Calvaruso, Antonio Craxì, Calogero Cammà, Vito Di Marco
What is the benefit of prophylaxis to prevent HBV reactivation in HBsAg-negative anti-HBc-positive patients? Meta-analysis and decision curve analysis. Liver international : official journal of the International Association for the Study of the Liver (2024)
Francesco Vizzutti, Ciro Celsa, Vincenza Calvaruso, Marco Enea, Salvatore Battaglia, Laura Turco, Marco Senzolo, Silvia Nardelli, Roberto Miraglia, Davide Roccarina, Claudia Campani, Dario Saltini, Cristian Caporali, Federica Indulti, Stefano Gitto, Alberto Zanetto, Gabriele Di Maria, Marcello Bianchini, Maddalena Pecchini, Silvia Aspite, Chiara Di Bonaventura, Michele Citone, Tomas Guasconi, Fabrizio Di Benedetto, Umberto Arena, Fabrizio Fanelli, Luigi Maruzzelli, Oliviero Riggio, Patrizia Burra, Antonio Colecchia, Erica Villa, Fabio Marra, Calogero Cammà, Filippo Schepis
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model. Hepatology (Baltimore, Md.) (2022)
Francesco Vizzutti, Ciro Celsa, Salvatore Battaglia, Roberto Miraglia, Marco Enea, Fabio Marra, Antonio Colecchia, Calogero Cammà, Filippo Schepis
Reply. Hepatology (Baltimore, Md.) (2022)
Paolo Giuffrida, Ciro Celsa, Michela Antonucci, Marta Peri, Maria Vittoria Grassini, Gabriele Rancatore, Carmelo Marco Giacchetto, Roberto Cannella, Antonio Russo, Lidia Rita Corsini, Piera Morana, Claudia La Mantia, Giuseppe Badalamenti, Giuseppe Brancatelli, Calogero Cammà, Giuseppe Cabibbo
The Evolving Scenario in the Assessment of Radiological Response for Hepatocellular Carcinoma in the Era of Immunotherapy: Strengths and Weaknesses of Surrogate Endpoints. Biomedicines 10 (11) (2022)
Federica Vernuccio, Roberto Cannella, Giuseppe Cabibbo, Silvia Greco, Ciro Celsa, Francesco Matteini, Paolo Giuffrida, Massimo Midiri, Vito Di Marco, Calogero Cammà, Giuseppe Brancatelli
Role of LI-RADS Indeterminate Observations in the Risk of Hepatocellular Carcinoma after HCV Eradication with Direct-Acting Antivirals. Diagnostics (Basel, Switzerland) 12 (5) (2022)
Francesco Vizzutti, Ciro Celsa, Salvatore Battaglia, Roberto Miraglia, Marco Enea, Fabio Marra, Cristian Caporali, Calogero Cammà, Filippo Schepis
Reply. Hepatology (Baltimore, Md.) (2022)
Roberto Cannella, Carla Cammà, Francesco Matteini, Ciro Celsa, Paolo Giuffrida, Marco Enea, Albert Comelli, Alessandro Stefano, Calogero Cammà, Massimo Midiri, Roberto Lagalla, Giuseppe Brancatelli, Federica Vernuccio
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC. Diagnostics (Basel, Switzerland) 12 (6) (2022)
Ciro Celsa, Calogero Cammà
Editorial: proton pump inhibitor use in cirrhosis-a piece of the puzzle. Alimentary pharmacology & therapeutics 53 (5) (2021)
Brian I Carr, Vito Guerra, Rossella Donghia, Fabio Farinati, Edoardo Giovanni Giannini, Luca Muratori, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Ciro Celsa, Claudia Campani, Andrea Mega, Maria Guarino, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Elisabetta Biasini, Alberto Masotto, Gerardo Nardone, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Maurizia Rossana Brunetto, Franco Trevisani
Identification of Clinical Phenotypes and Related Survival in Patients with Large HCCs. Cancers 13 (4) (2021)
Ciro Celsa, Giuseppe Cabibbo, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Anita Busacca, Paolo Giuffrida, Caterina Stornello, Giuseppe Brancatelli, Roberto Cannella, Salvatore Gruttadauria, Calogero Cammà
Are radiological endpoints surrogate outcomes of overall survival in hepatocellular carcinoma treated with transarterial chemoembolization? Liver international : official journal of the International Association for the Study of the Liver 41 (5) (2021)
Víctor Sapena, Marco Enea, Ferràn Torres, Ciro Celsa, Jose Ríos, Giacomo Emanuele Maria Rizzo, Pierre Nahon, Zoe Mariño, Ryosuke Tateishi, Tatsuya Minami, Angelo Sangiovanni, Xavier Forns, Hidenori Toyoda, Stefano Brillanti, Fabio Conti, Elisabetta Degasperi, Ming-Lung Yu, Pei-Chien Tsai, Kévin Jean, Mohamed El Kassas, Hend Ibrahim Shousha, Ashraf Omar, Claudio Zavaglia, Hiroko Nagata, Mina Nakagawa, Yasuhiro Asahina, Amit G Singal, Caitlin C Murphy, Mohamed Ahmed Samy Kohla, Chiara Masetti, Jean-François Dufour, Nicolás Merchante, Luisa Cavalletto, Liliana Lc Chemello, Stanislas Pol, Javier Crespo, Jose Luis Calleja, Rosanna Villani, Gaetano Serviddio, Alberto Zanetto, Sarah Shalaby, Francesco Paolo Russo, Rob Bielen, Franco Trevisani, Calogero Cammà, Jordi Bruix, Giuseppe Cabibbo, Maria Reig
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis. Gut (2021)
Bianca Magro, Valentina Zuccaro, Luca Novelli, Lorenzo Zileri, Ciro Celsa, Federico Raimondi, Mauro Gori, Giulia Cammà, Salvatore Battaglia, Vincenzo Giuseppe Genova, Laura Paris, Matteo Tacelli, Francesco Antonio Mancarella, Marco Enea, Massimo Attanasio, Michele Senni, Fabiano Di Marco, Luca Ferdinando Lorini, Stefano Fagiuoli, Raffaele Bruno, Calogero Cammà, Antonio Gasbarrini
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use. PloS one 16 (1) (2021)
Filippo Pelizzaro, Alessandro Vitale, Anna Sartori, Andrea Vieno, Barbara Penzo, Francesco Paolo Russo, Anna Chiara Frigo, Edoardo Giovanni Giannini, Manuela Piccinnu, Gian Ludovico Rapaccini, Maria Di Marco, Eugenio Caturelli, Marco Zoli, Rodolfo Sacco, Ciro Celsa, Fabio Marra, Andrea Mega, Maria Guarino, Antonio Gasbarrini, Gianluca Svegliati-Baroni, Francesco Giuseppe Foschi, Andrea Olivani, Alberto Masotto, Pietro Coccoli, Giovanni Raimondo, Francesco Azzaroli, Gianpaolo Vidili, Maurizia Rossana Brunetto, Franco Trevisani, Fabio Farinati, null On Behalf Of Ita Li Ca Study Group
Surveillance as Determinant of Long-Term Survival in Non-Transplanted Hepatocellular Carcinoma Patients. Cancers 13 (4) (2021)
Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Stefania Grimaudo, Domenica Matranga, Massimo Attanasio, Paolo Bruzzi, Antonio Craxì, Calogero Cammà
Optimizing Sequential Systemic Therapies for Advanced Hepatocellular Carcinoma: A Decision Analysis. Cancers 12 (8) (2020)
Giuseppe Cabibbo, Ciro Celsa, Marco Enea, Salvatore Battaglia, Giacomo Emanuele Maria Rizzo, Anita Busacca, Domenica Matranga, Massimo Attanasio, Maria Reig, Antonio Craxì, Calogero Cammà
Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma. Cancers 13 (1) (2020)
Grazia Pennisi, Ciro Celsa, Antonina Giammanco, Federica Spatola, Salvatore Petta
The Burden of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: Screening Issue and Future Perspectives. International journal of molecular sciences 20 (22) (2019)
Grazia Pennisi, Ciro Celsa, Federica Spatola, Marcello Dallio, Alessandro Federico, Salvatore Petta
Pharmacological Therapy of Non-Alcoholic Fatty Liver Disease: What Drugs Are Available Now and Future Perspectives. International journal of environmental research and public health 16 (22) (2019)
Giuseppe Cabibbo, Alessandro Cucchetti, Calogero Cammà, Andrea Casadei-Gardini, Ciro Celsa, Giacomo Emanuele Maria Rizzo, Philip Johnson, Giorgio Ercolani
Outcomes of hepatocellular carcinoma patients treated with sorafenib: a meta-analysis of Phase III trials. Future oncology (London, England) 15 (29) (2019)
Matteo Tacelli, Ciro Celsa, Bianca Magro, Aurora Giannetti, Grazia Pennisi, Federica Spatola, Salvatore Petta
Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once? Pharmaceuticals (Basel, Switzerland) 11 (4) (2018)
Giuseppe Cabibbo, Ciro Celsa, Calogero Cammà, Loreta A Kondili
Should we cure hepatitis C virus in patients with hepatocellular carcinoma while treating cancer? Liver international : official journal of the International Association for the Study of the Liver 38 (12) (2018)